The interventional radiology product market is projected to reach USD 23.9 billion in 2024. The interventional radiology product are projected to expand at a CAGR of 7.4% from 2024 to 2034. The global interventional radiology product market is expected to reach USD 48.8 billion by 2034.
Attributes | Key Insights |
---|---|
Estimated Market Size in 2024 | USD 23.9 billion |
Projected Market Value in 2034 | USD 48.8 billion |
Value-based CAGR from 2024 to 2034 | 7.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The interventional radiology product market accounted for a 9% CAGR from 2019 to 2023. A growing focus on improving medical facilities may result in growth in the interventional radiology market in emerging markets. Equipment and product used in interventional radiology may be in higher demand.
Regulatory and healthcare policy changes can have an impact on the market. Stringent regulatory approvals can slow the introduction of new product, while manufacturers can gain an advantage by implementing favorable regulations.
The prevalence of chronic diseases, such as cardiovascular diseases and cancer, often drives the demand for interventional radiology procedures and related product. These conditions will become more common with an aging population, contributing to market growth. A CAGR of 7.4 % is forecast between 2024 and 2034.
Historical CAGR from 2019 to 2023 | 9% |
---|---|
Forecast CAGR from 2024 to 2034 | 7.4% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section analyzes the interventional radiology product market across key countries, including the United States, United Kingdom, China, Japan, and South Korea. The analysis delves into the specific factors driving the demand for interventional radiology product in these countries.
Countries | Forecast CAGRs from 2024 to 2034 |
---|---|
The United States | 7.7% |
The United Kingdom | 6% |
China | 8.3% |
Japan | 6.6% |
South Korea | 5% |
The United States is expected to expand at a CAGR of 7.7% between 2024 and 2034. Continuous technological advancements drive the demand for interventional radiology product in the United States. Interventional radiology product manufacturers in the United States are quickly adopting new and innovative technologies to improve patient outcomes.
The United States is one of the countries with the highest healthcare expenditures in the world. Due to their financial strength, healthcare facilities can invest in the latest interventional radiology equipment and procedures. In the United States, interventional radiology products are in high demand because chronic conditions like cardiovascular disease and cancer are prevalent. Regulatory environments strictly enforces safety and efficacy standards, widening sales prospects.
This section illustrates the market's leading segment. the stent segment is expected to exhibit a CAGR of 7.2% in 2024. Cardiology is expected to experience a CAGR of 6.9% from 2024 to 2034.
Category | CAGR from 2024 to 2034 |
---|---|
Stent | 7.2% |
Cardiology | 6.9% |
Stents have gained considerable market share as the incidence of heart disease and cancer is on the rise. In addition, the number of angioplasty procedures performed worldwide continues to grow. A CAGR of 7.2% is expected for the stent market from 2024 to 2034.
Increasing patient outcomes and reducing complications also contribute to the demand for stents, as bioresorbable and drug-eluting devices are being developed. Due to the growing popularity of minimally invasive procedures that reduce patient trauma and recovery time, the demand for stents is on the rise.
With the growing geriatric population and the increasing prevalence of cardiovascular diseases (CVD), interventional cardiology devices are in demand. Technological advances have led to significant advances in cardiology, including robotic surgical techniques and advanced imaging. Improvements in diagnostic accuracy and treatment precision aim to improve patient outcomes.
Cardiology is increasingly focused on personalized medicine. Personalized treatment plans are tailored for each individual based on genetic characteristics, lifestyle factors, and medical histories. Optimizing treatment effectiveness and minimizing side effects are the goals of personalized medicine. A CAGR of 6.9% is projected for the market during the forecast period.
Integrated healthcare technologies and telemedicine are gaining traction in cardiology. Using these technologies, cardiovascular health can be monitored remotely, teleconsulted, and managed using mobile applications. Early detection of cardiac conditions can be facilitated, and access to care can be improved.
Partnerships and collaborations between market players, research organizations, and healthcare organizations are common. Through these collaborations, knowledge is shared, technology is transferred, and new product are developed together. Innovation can be accelerated, and interventional radiology demand can be driven by leveraging collective expertise and resources.
Key Market Developments
Attributes | Details |
---|---|
Estimated Market Size in 2024 | USD 23.9 billion |
Projected Market Valuation in 2034 | USD 48.8 billion |
Value-based CAGR 2024 to 2034 | 7.4% |
Forecast Period | 2024 to 2034 |
Historical Data Available for | 2019 to 2023 |
Market Analysis | Value in USD billion |
Key Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East and Africa |
Key Market Segments Covered | Type, Application, End User, Region |
Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, Poland, Russia, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel |
Key Companies Profiled | Boston Scientific Corporation; Abbott; Cardinal Health; Cook; Stryker; Braun Melsungen AG; Terumo Corporation; General Electric; Koninklijke Philips N.V.; Carestream Health; ESAOTE SPA; Hitachi. Ltd.; Hologic, Inc.; Shimadzu Corporation; Siemens Healthcare GmbH |
In 2024, the market size for interventional radiology product is estimated to be USD 23.9 billion.
The market for interventional radiology product is expected to reach USD 48.8 billion in 2034.
A CAGR of 7.4% is projected for the interventional radiology product market from 2024 to 2034.
As per forecasts, the stent segment will increase at a CAGR of 7.2% by 2024.
The United States, China, the United Kingdom, Japan, and South Korea are expected to lead the market.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type 5.1. Stents 5.2. Catheters 5.3. Inferior Vena Cava (IVC) Filters 5.4. Embolization Devices 5.5. Thrombectomy Systems 5.6. Angioplasty Balloons 5.7. Biopsy Needles 5.8. Hemodynamic Flow Alteration Devices 5.9. Accessories 5.10. Others 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 6.1. Cardiology 6.2. Oncology 6.3. Gastroenterology 6.4. Neurology 6.5. Orthopedics 6.6. Urology and Nephrology 6.7. Others 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 7.1. Hospitals 7.2. Clinics 7.3. Home Care Settings 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Boston Scientific Corporation 18.2. Abbott 18.3. Cardinal Health 18.4. Cook 18.5. Stryker 18.6. Braun Melsungen AG 18.7. Terumo Corporation 18.8. General Electric 18.9. Koninklijke Philips N.V. 18.10. Carestream Health 18.11. ESAOTE SPA 18.12. Hitachi, Ltd. 18.13. Hologic, Inc. 18.14. Shimadzu Corporation 18.15. Siemens Healthcare GmbH 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports